A brief description of the instructions for use of the Bangladeshi version of generic neratinib

Neratinib is an oral, irreversible tyrosine kinase inhibitor developed and produced by Puma Biotechnology, Inc., which is mainly used to treat HER2-positive breast cancer. It achieves the purpose of anti-cancer by inhibiting the transduction of EGFR, HER2 and HER4 signaling pathways. It can significantly reduce the risk of breast cancer recurrence, but the high price of the original drug limits its popularity, while the Bangladeshi version of the generic drug provides patients with a more economical treatment option. This article will briefly introduce the instructions for use of the Bangladeshi version of the generic drug neratinib.

1. Indications, usage and dosage

1. Indications:

For extended adjuvant treatment of adult patients with early-stage HER2-positive breast cancer who have previously received adjuvant trastuzumab treatment.

Combined with capecitabine for the treatment of adult patients with metastatic advanced breast cancer who have received two or more treatment regimensAdult patients with HER2-positive breast cancer.

2. Usage and dosage:

Extended adjuvant therapy for early breast cancer: The recommended dose is 240 mg once daily (equivalent to six 40 mg tablets), taken with food, and continued for at least one year.

Advanced or metastatic breast cancer: 240 mg once daily on days 1-21 of a 21-day cycle until disease progression or unacceptable toxicity.

Please note that the specific dosage may need to be adjusted according to the patient's liver function, tolerance and other factors, and must be used under the guidance of a doctor.

2. Adverse reactions and precautions

Common adverse reactions include diarrhea, nausea, vomiting, abdominal pain, fatigue, rash, loss of appetite, muscle cramps, etc. Some patients may have severe diarrhea and need to replenish water and electrolytes in time. Liver function should be tested before treatment and monitored regularly during treatment. If there are any abnormalities, seek medical advice in time to adjust the treatment plan.

Precautions for special groups: Pregnant and lactating women are not allowed to use this product because this product may cause harm to fetuses and infants; Patients with severe liver damage should reduce the starting dose to80mg; the safety and effectiveness of this product have not been established for children, and its use is not recommended.

3. Drug interactions

This product may interact with certain drugs, such as antacids. Therefore, if you need to take other drugs together while using this product, be sure to inform your doctor to avoid potential drug interactions.

4. Storage conditions

This product should be stored at room temperature20°C to 25°C. The allowed temperature range is 15-30°C when taken out. Please keep the medicine dry and away from direct sunlight.

5. Specifications and selling price

The generic drug of neratinib produced by Bangladesh Yaopin International comes in two specifications, 40mg*180 tablets/40mg*30 tablets. The price is about more than 1,000 to more than 3,000 yuan. Patients should choose according to their needs.

In short, the Bangladeshi version of the generic version of neratinib (neratinib) provides patients with more treatment options, but its use must still strictly follow medical instructions to ensure that the medication is safe and effective. Patients should pay close attention to their own reactions during use and seek medical consultation in time if they experience any discomfort. At the same time, you should also pay attention to identifying the authenticity of medicines and choose regular channels to purchase them to ensure the quality of medicines.